CAS: 149082-03-1; (3,5-Dimethyl-4-Nitropyridin-2-yl)Methanol

该化合物是一种有机化合物,其特征为:环,是六人组成的芳香热循环,含有一个氮原子;该化合物的特征为:3和5个基座上有两个甲基组,4个基座上有一个硝基组,有助于形成其独特的化学特性;2个基位上的氢氧甲基组(-CH2OH)的存在增强了其在极地溶剂中的再活性和溶性;硝基甲组以其电镀特性而著称,它可以影响该化合物在各种化学反应中的再活动,包括核生殖器替代和减少;此外,该化合物可能展示生物活动,使其对制药研究感兴趣;其分子结构表明有机合成和作为中间体的其他化学实体生产中的潜在应用;在处理时,应参考安全数据,因为硝基化合物可能具有敏感性并可能构成健康风险.

结构式图片

相似化合物

168167-49-5 143016-69-7 142885-95-8

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号86604-79-7 4-硝基-2,3,5-三甲基吡... | CAS号695-98-7 2,3,5-三甲基吡啶 | CAS号74409-42-0 2,3,5-三甲基吡啶 N-氧化物

合成工艺路线路线简述

    📜2,3,5-三甲基吡啶 1-氧化物置于硫酸,硝酸,Potassium Carbonate体系中,用 甲醇 用作溶剂,化学反应 24.0H,反应生成3,5-二甲基-4-硝基吡啶-2-甲醇
    参考文献:Rationally Designed High-Affinity 2-Amino-6-Halopurine Heat Shock Protein 90 Inhibitors That Exhibit Potent Antitumor Activity
    标题:Rationally Designed High-Affinity 2-Amino-6-Halopurine Heat Shock Protein 90 Inhibitors That Exhibit Potent Antitumor Activity
    摘要:Heat Shock Protein 90 (Hsp90) Is A Molecular Chaperone Protein Implicated In Stabilizing The Conformation And Maintaining The Function Of Many Cell-Signaling Proteins. Many Oncogenic Proteins Are More Dependent On Hsp90 In Maintaining Their Conformation,Stability,And Maturation Than Their Normal Counterparts. Furthermore,Recent Data Show That Hsp90 Exists In An Activated Form In Malignant Cells But In A Latent Inactive Form In Normal Tissues,Suggesting That Inhibitors Selective For The Activated Form Could Provide A High Therapeutic Index. Hence,Hsp90 Is Emerging As An Exciting New Target For The Treatment Of Cancer. We Now Report On A Novel Series Of 2-Amino-6-Halopurine Hsp90 Inhibitors Exemplified By 2-Amino-6-Chloro-9-(4-Iodo-3,5-Dimethylpyridin-2-Ylmethyl)Purine (30). These Highly Potent Inhibitors (Ic50 Of 30 = 0.009 Mu M In A Her-2 Degradation Assay) Also Display Excellent Antiproliferative Activity Against Various Tumor Cell Lines (Ic50 Of 30 = 0.03 Mu M In Mcf7 Cells). Moreover,This Class Of Inhibitors Shows Higher Affinity For The Activated Form Of Hsp90 Compared To Our Earlier 8-Sulfanylpurine Hsp90 Inhibitor Series. When Administered Orally To Mice,These Compounds Exhibited Potent Tumor Growth Inhibition (> 80%) In An N87 Xenograft Model,Similar To That Observed With 17-Allylamino-17-Desmethoxygeldanamycin (17-Aag),Which Is A Compound Currently In Phase I/ii Clinical Trials.
    Doi:10.1021/jm050752+

    海关参考信息

    专利信息


    专利号:WO-0000474-A1
    优先权日:1998-06-26
    标题:Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
    发明人:NIKOLOPOULOS ANGELO; SCHICKANEDER HELMUT; KOCHER CHRISTIAN; MURPHY TREVOR; HERMANN GESINE
    权利人:RUSSINSKY LTD; NIKOLOPOULOS ANGELO; SCHICKANEDER HELMUT; KOCHER CHRISTIAN; MURPHY TREVOR; HERMANN GESINE
    摘要:Complexes of formulae (II or III) are useful intermediates for preparing compounds of formula (IV) which in turn may be converted into a pyridine benzimidazole.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.bmcl.2019.02.025
    摘要:Green KD, Fosso MY, Mayhoub AS, Garneau-Tsodikova S. Investigating the promiscuity of the chloramphenicol nitroreductase from Haemophilus influenzae towards the reduction of 4-nitrobenzene derivatives. Bioorganic & Medicinal Chemistry Letters. 2019 May;29(9):1127–32. doi: 10.1016/j.bmcl.2019.02.025.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知